An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBenÂ®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults